Opening an account with a compounding pharmacy

What is actually being opened?

A record that the supplier is allowed to sell to you — held by the supplier, for the supplier's own regulator.

This is worth getting right at the start, because it explains every step that follows. In several of the states we have read, the duty to establish that a purchaser is authorised sits on the supplier's licence, not on the buyer's diligence. Arizona requires a nonresident outsourcing facility to "maintain a copy of the current permit or license of each person in Arizona that buys, receives, or disposes of" the drug, and the parallel rule for nonresident pharmacies requires that copy to be producible within two business days. Louisiana binds distributors to "sell or distribute legend drugs or legend devices only to a person who is authorized, by law or regulation, to procure or possess legend drugs or legend devices."

So a pharmacy asking for your licence is not gatekeeping. It is the thing its own regulator will ask it to produce.

What decides how long it takes?

Verification against an authority neither party controls.

The documents themselves are quick. What sets the pace is that a licence has to be confirmed as current with the board that issued it, and where a practice operates across state lines the confirmations multiply. A supplier that skips that step has not saved you time — it has created a gap in the file its regulator will look at.

The corollary is useful in the other direction: an account that opens implausibly fast, with no verification step you can see, is telling you something about how that supplier keeps its records. What a pharmacy checks, and against which registries, is set out at prescriber credentialing: what pharmacies verify.

What comes first?

Scoping, and it is the step most often skipped.

Two questions decide what kind of account you need before a single document changes hands. First, will you be ordering against prescriptions for identified individual patients, or holding stock that names no patient? Those are different transactions under different federal provisions and they are not filled by the same kind of supplier. Second, in which states will the product be received?

Getting these the wrong way round is the common failure. A practice that fills in an application, sends its licences and then discovers its state prohibits what it wanted has spent the effort in the wrong order. Both questions are worked through at how clinics order compounded medications, which is the map this page sits inside.

What does the supplier need from you?

Enough to establish, and keep evidence of, your authority to receive what you are ordering.

The specific list varies with the pathway, the state and whether controlled substances are involved, so the enumerated version lives on its own page at what documents a compounding pharmacy needs from your clinic. What is worth understanding here is the shape: identity and authority for the prescriber, identity and authority for the receiving site, and — where the state imposes one — a facility credential belonging to the practice rather than to the prescriber.

That last category catches people out. Ohio's guidance treats a prescriber practice holding dangerous drugs as needing a terminal distributor licence, while naming possession of compounded preparations supplied by an Ohio-licensed outsourcing facility as a lower-risk activity that does not itself trigger licensure. Florida requires a health care clinic establishment permit where a business entity purchases prescription drugs, with an express carve-out for purchases made by a licensed practitioner under their own licence.

Is a written agreement required?

In some states, for some transactions, yes — and it is a rule requirement rather than a contract preference.

Texas's office-use rules require a written agreement between the pharmacy and the practitioner. Georgia's veterinary channel specifies content: the agreement must record the practitioner's agreement that the preparation "may only be administered to the patient and may not be dispensed to the patient or sold to any other person or entity," subject to a narrow emergency exception, and the practitioner must chart the lot number and the beyond-use date.

Both of those attach to non-patient-specific supply rather than to ordinary prescription fulfilment. If a supplier proposes an agreement of this kind, the useful question is which rule it is satisfying, because the answer tells you which transaction they believe they are running.

What changes if you practise in more than one state?

The number of credentials that have to line up, on both sides.

Your own authority is a state question. So is the supplier's: an outsourcing facility's FDA registration is a federal exemption from federal law and preempts nothing at state level, so it needs the destination state's credential as well. California's nonresident outsourcing licence, for example, comes with an annual on-site inspection reimbursed at the facility's expense — a condition that quietly narrows the field of facilities able to ship there.

The result is that "we are licensed" is an incomplete answer from a supplier and an incomplete answer from a practice. The per-state version of this is at multi-state practice ordering: what changes per state.

What can stall or fail an account?

Four things, in roughly descending order of how often they are the real cause.

A licence that cannot be verified as current — expired, mid-renewal, or issued under a name that does not match the application. A mismatch between the site receiving the product and the site named on the credential, which matters because several states register authority per location rather than per practitioner. A request for a transaction the destination state does not permit at all, which no amount of paperwork resolves. And a supplier that does not hold the destination state's credential, which is the supplier's problem but becomes yours at the point the order does not ship.

None of these is discovered faster by sending more documents. Each is discovered faster by asking, at the start, which state and which transaction.

What should you ask before you open one?

The questions that are cheapest to ask first and most expensive to ask later.

Which states does the supplier hold credentials in, and issued by which agency — because it is not always the board of pharmacy. Which pathway will fill your order. What the supplier will need to keep on file about you, and for how long. And, if they are proposing non-patient-specific supply into your state, which rule they say permits it.

A supplier that answers those precisely is a different proposition from one that answers them warmly. The fuller diligence checklist, including what to check independently rather than take on trust, is at how to vet a compounding pharmacy.

What this page does not cover

Two adjacent things that have their own pages.

It does not describe placing an order once the account exists — what an order contains, what the pharmacy needs on it, and what comes back. And it does not decide whether your state permits your practice to hold stock, which is the question that most often determines whether an account of the kind you had in mind is available to you at all.

If you would rather have your state, your practice type and your intended preparations mapped against the two pathways before you start any of this, you can apply for an account.